Title : Improving the Efficiency of Precise Genome Editing with CRISPR\/Cas9 to Generate Goats Overexpressing Human Butyrylcholinesterase - Wang_2023_Cells_12_ |
Author(s) : Wang JH , Wu SJ , Li Y , Zhao Y , Liu ZM , Deng SL , Lian ZX |
Ref : Cells , 12 : , 2023 |
Abstract :
The CRISPR/Cas9 system is widely used for genome editing in livestock production, although off-target effects can occur. It is the main method to produce genome-edited goats by somatic cell nuclear transfer (SCNT) of CRISPR/Cas9-mediated genome-edited primary goat fetal fibroblast cells (GFFs). Improving the double-strand break (DSB) efficiency of Cas9 in primary cells would improve the homologous repair (HR) efficiency. The low efficiency of HR remains a major hurdle in CRISPR/Cas9-mediated precise genome editing, increasing the work required to screen the genome-edited primary cell clones. In this study, we modified several essential parameters that affect the efficiency of the CRISPR/Cas9-mediated knock-in GFF cloning system, including establishing a high-efficiency transfection system for primary cells via nucleofection and optimizing homology arm (HA) length during HR. Here, we specifically inserted a recombinant human butyrylcholinesterase gene (rhBChE) into the goat fibroblast growth factor (FGF)-5 locus through the CRISPR/Cas9 system, thereby achieving simultaneous rhBChE insertion and FGF5 knock-out. First, this study introduced the Cas9, FGF5 knock-out small guide RNA, and rhBChE knock-in donors into GFFs by electroporation and obtained positive cell clones without off-target effects. Then, we demonstrated the expression of rhBChE in GFF clones and verified its function. Finally, we obtained a CRISPR/Cas9-mediated rhBChE-overexpression goat. |
PubMedSearch : Wang_2023_Cells_12_ |
PubMedID: 37508483 |
Wang JH, Wu SJ, Li Y, Zhao Y, Liu ZM, Deng SL, Lian ZX (2023)
Improving the Efficiency of Precise Genome Editing with CRISPR\/Cas9 to Generate Goats Overexpressing Human Butyrylcholinesterase
Cells
12 :
Wang JH, Wu SJ, Li Y, Zhao Y, Liu ZM, Deng SL, Lian ZX (2023)
Cells
12 :